The increase in vaccine procurement is good news in terms of daily vaccination numbers, but govt's stated target of 1 crore daily vaccinations still some time away.
Talks are still on with Moderna, Sputnik yet to be procured for the national Covid vaccination programme, which means Covishield and Covaxin will remain the mainstay.
Pune-based vaccine manufacturer SII has already received cell and vector samples for the production of Sputnik V from Russia's Gamaleya Center, the developer of the vaccine.
Russia's RDIF has also reached agreements with other pharmaceutical companies in India including Gland Pharma, Hetero Biopharma, Panacea Biotec, Stelis Biopharma & Virchow Biotech.
Dr Reddy's, through which Russia's Sputnik V is available in India, said the timeline was pushed a little further due to import dependency, quality checks.
Dr Reddy's Laboratories is in a pact with Russian Direct Investment Fund to sell the first 250 million vials of Sputnik V in India. It has already received nearly 3 million doses.
The permission has been granted for examination, test and analysis of the Sputnik vaccine at SII's licensed Hadapsar facility under certain conditions, official sources said.
New CPI series will take 2024 as base year, will provide more accurate measure of inflation, spending on digital services. Expected to enhance representation and reliability, says Saurabh Garg.
The agreement, signed after meeting between Rajnath and US Secretary of War Pete Hegseth on sidelines of ADMM-Plus in Kuala Lumpur, aims to deepen bilateral ties in the critical sector.
This world is being restructured and redrawn by one man, and what’s his power? It’s not his formidable military. It’s trade. With China, it turned on him.
COMMENTS